2023 international evidence-based guideline pcos glp-1 receptor agonist Beneficial effects of agonists on (created in Liraglutide and polycystic ovary syndrome:

Lipid improvements Retatrutide produces substantial improvements in lipid profiles

The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion

Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia

However, the reduction in HF hospitalisations with semaglutide did not reach statistical significance

[DOI] [PubMed] [Google Scholar] 294.Edfalk S., Steneberg P., Edlund H